Study title:
Komp-D-M, Britton-H-A, Vietti-T-J, Humphrey-G-B.
Southwest Oncol. Group, Operations Office, 3500 Rainbow Blvd, Suite 201, Kansas City, Kans. 66103, United States.
Response of childhood histiocytosis X to procarbazine (NSC 77213).
CANCER-CHEMOTHER-REP, 1974, Vol/Iss/Pg. 58/5 (719-722).
Komp-D-M, Britton-H-A, Vietti-T-J, Humphrey-G-B.
Southwest Oncol. Group, Operations Office, 3500 Rainbow Blvd, Suite 201, Kansas City, Kans. 66103, United States.
Response of childhood histiocytosis X to procarbazine (NSC 77213).
CANCER-CHEMOTHER-REP, 1974, Vol/Iss/Pg. 58/5 (719-722).
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Neoplasms [C04]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: PROCARBAZINE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|